chr5-79728924-C-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_153610.5(CMYA5):c.159C>A(p.Asp53Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00641 in 1,547,718 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_153610.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CMYA5 | NM_153610.5 | c.159C>A | p.Asp53Glu | missense_variant | 2/13 | ENST00000446378.3 | |
CMYA5 | XM_047416911.1 | c.159C>A | p.Asp53Glu | missense_variant | 2/6 | ||
CMYA5 | XR_001742036.3 | n.231C>A | non_coding_transcript_exon_variant | 2/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CMYA5 | ENST00000446378.3 | c.159C>A | p.Asp53Glu | missense_variant | 2/13 | 5 | NM_153610.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00510 AC: 775AN: 151838Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00426 AC: 943AN: 221340Hom.: 4 AF XY: 0.00412 AC XY: 497AN XY: 120580
GnomAD4 exome AF: 0.00656 AC: 9150AN: 1395762Hom.: 38 Cov.: 29 AF XY: 0.00638 AC XY: 4417AN XY: 692494
GnomAD4 genome AF: 0.00510 AC: 775AN: 151956Hom.: 2 Cov.: 32 AF XY: 0.00465 AC XY: 345AN XY: 74272
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | CMYA5: BS2 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at